Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma
Jul 21, 2021
Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence,...
Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility
Jul 15, 2021
6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full...
ACCELA webinar recording : IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jul 15, 2021
Intravital microscopy can visualize...
Webinar recording: Autofluorescence management - the power of Spectral Flow Cytometry
Jul 15, 2021
One of the key advantages of spectral flow cytometry is its ability to extract sample...
Webinar recording: Super-Resolution imaging of Chromatin organization in health and disease
Jul 9, 2021
Understanding how cells organize the array of components within their membranous confines can not only provide insight...
Jul 8, 2021
NanoView Biosciences has developed...
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles
Jul 3, 2021
Overactivation of the PI3K/mTOR signaling has been identified in non-Hodgkin’s lymphoma....
Quantitative two-photon microscopy imaging analysis of human skin
Jul 1, 2021
Transdermal skin delivery is a method to transport various topical formulations to a deeper skin layer non-invasively....
OMIXYS Educational webinar series: IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jun 11, 2021
Intravital microscopy can visualize...
Jun 10, 2021
NanoView Biosciences has developed...
Studying cancer biology and therapeutic targets using PET technology
Jan 18, 2018
Bruker Albira technology offers advanced imaging techniques for experiments in living animals. Seamless integration of PET, SPECT and CT in one compact footprint allows the study of a full range of biological processes, including gene expression, enzyme and protein activity, progression and treatment of diseases, and the biodistribution, pharmacodynamics or pharmacokinetics of new drugs.
And the most recently released model, the Bruker Albira Si, is the first commercially available PET system to feature advanced silicon photomultipliers (SiPM) technology. SiPM offers major advantages over traditional PET technology by delivering the highest Full Field of View Accuracy (FFA) imaging and quantification and full MRI compatibility.
Do you want to know more? Watch te recorded webinar with Professor Sambuceti and his team at the Nuclear Medicine Unit, Department of Health Sciences, University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy and learn how they identified a previously unknown way of processing glucose in cancer cells through the application of microPET imaging!
Brand profile
